Sunrest Lifescience IPO

Incorporated in 2017, Sunrest Lifescience operates in the domestic market, focusing on marketing OTC generic pharmaceutical products. They offer a variety of pharmaceutical products sourced from third-party manufacturers. The company has a presence in different states of India, including Maharashtra, Gujarat, Madhya Pradesh, Orissa, and Rajasthan. Their presence in these states is established through both trademark-registered products and products currently under registration. Sunrest Lifescience deals in various pharmaceutical products, including capsules, tablets, syrup, ointment, gel, mouthwash, solution, suspension, dry powders, and toothpaste. Their product portfolio encompasses a broad spectrum of drugs, such as anti-bacterial, anti-diarrheal, antifungal, anti-material, anti-diabetic, dental cure, anti-protozoal, anti-histamine, anti-hypertensive drugs, cosmetic, anti-parasitic, multivitamin, multimineral, nutraceutical, and anti-inflammatory medications. The company holds 18 registered trademarks for 32 different products. The company’s products are distributed to stockists and super stockists, and they, in turn, make these products available in chemist shops, dispensaries, hospitals, and other similar establishments. ;